The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score -12.61 — distress zone — historically elevated failure riskWatch
- Earnings-manipulation signal · Beneish M -0.40 — flag raised, worth a closer lookWatch
- Earnings quality 58/100 — worth a closer lookWatch
Where the revenue comes from
Fiscal 2025, as MACROGENICS INC reports it. History and quarterly detail are in the app.
- Collaborative and other agreements$87.2M
- Contract manufacturing$52.6M
- RevenuesFromCMOAgreementsMember$36.8M
- Manufacturing Services$10.7M
- Revenues From License Agreements$9.7M
Leadership changes
From MACROGENICS INC's own filings, the day they're filed.
- Stephen Eck · Chief Medical Officer · departureeff. 2025-12-31
- Eric Risser · President · appointmenteff. 2025-08-13
- Lynn Cilinski · President · departureeff. 2025-01-02
Latest filings
- 10-Q · Quarterly report2026-08-14
- 8-K · Company announcement2026-08-13
- 8-K · Company announcement2026-07-23
- 8-K · Company announcement2026-07-08
- 8-K · Company announcement2026-07-07
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about MACROGENICS INC, every answer cited to the official filings🔒
- The Intelligence Brief — added when MACROGENICS INC's brief passes our SEC-figure check🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.